21 Aug 2019
We are proud to announce that NetTargets Inc. has been officially established as of 13 August 2019 and that its main office is located at (9F, National Nanofab Center, KAIST, Daejeon, Republic of Korea). Drs Minsoo Choi (CEO), Je-Hoon Song (CTO), Jongho Baek (COO & CFO), and Kwang-Hyun Cho (Scientific Advisor) co-founded NetTargets as the first startup company in Korea pursuing intelligent drug discovery and precision medicine based on strong scientific research on systems biology over last 20+ years.
NetTargets will innovate drug discovery and development through interdisciplinary research between life science and information technology. NetTargets welcomes joint projects in this direction with pharmaceutical companies and recruits talented young people who want to join the venture for developing the first-in-class novel drugs for complex human diseases.
We are delighted to announce that NetTargets has been named the Most Innovative Drug Discovery Company in East Asia at the Global Health and Pharma Biotechnology Awards 2023.
NetTargets will deliver a presentation at BIO KOREA 2023, to be held on 10-12 May at COEX, SEOUL (Presentation Schedule: May 11, 2023, 10:40 AM (KST)). It will also participate in partnering meetings and exhibit at the booth (no. Q25) during the conference.